Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accumulated Depreciation (2020 - 2025)

BioAtla (BCAB) has 6 years of Accumulated Depreciation data on record, last reported at $7.4 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation rose 8.59% year-over-year to $7.4 million; the TTM value through Sep 2025 reached $7.4 million, up 8.59%, while the annual FY2024 figure was $7.0 million, 15.22% up from the prior year.
  • Accumulated Depreciation reached $7.4 million in Q3 2025 per BCAB's latest filing, up from $7.0 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $7.4 million in Q3 2025 and bottomed at $3.7 million in Q2 2021.
  • Average Accumulated Depreciation over 5 years is $5.5 million, with a median of $5.3 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation: skyrocketed 38.66% in 2021, then increased 8.59% in 2025.
  • A 5-year view of Accumulated Depreciation shows it stood at $4.3 million in 2021, then rose by 26.0% to $5.4 million in 2022, then grew by 13.31% to $6.1 million in 2023, then grew by 15.22% to $7.0 million in 2024, then rose by 5.05% to $7.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation were $7.4 million in Q3 2025, $7.0 million in Q4 2024, and $6.8 million in Q3 2024.